Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Recurrent/Persistent Low Risk Gestational Trophoblastic Tumor
NCT00190918Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in gestational trophoblastic tumor (GTN), sponsored by Eli Lilly and Company. Started Jul 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
gestational trophoblastic tumor (GTN)
Beyond the preview
Go deeper on NCT00190918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190918.